Sonendo (SONX) Competitors $0.30 0.00 (0.00%) As of 10/6/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock SONX vs. TTOO, IONM, SDCCQ, GMVDF, VRAYQ, AFIB, NMRD, VIVE, UTRS, and MOTSShould you be buying Sonendo stock or one of its competitors? The main competitors of Sonendo include T2 Biosystems (TTOO), Assure (IONM), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Acutus Medical (AFIB), Nemaura Medical (NMRD), Viveve Medical (VIVE), Minerva Surgical (UTRS), and Motus GI (MOTS). These companies are all part of the "medical equipment" industry. Sonendo vs. Its Competitors T2 Biosystems Assure SmileDirectClub G Medical Innovations ViewRay Acutus Medical Nemaura Medical Viveve Medical Minerva Surgical Motus GI T2 Biosystems (NASDAQ:TTOO) and Sonendo (NYSE:SONX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation. Does the media refer more to TTOO or SONX? In the previous week, T2 Biosystems had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for T2 Biosystems and 0 mentions for Sonendo. T2 Biosystems' average media sentiment score of 0.00 equaled Sonendo'saverage media sentiment score. Company Overall Sentiment T2 Biosystems Neutral Sonendo Neutral Is TTOO or SONX more profitable? Sonendo has a net margin of -92.74% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Sonendo's return on equity.Company Net Margins Return on Equity Return on Assets T2 Biosystems-563.16% N/A -174.06% Sonendo -92.74%-184.01%-68.60% Do institutionals & insiders believe in TTOO or SONX? 23.2% of T2 Biosystems shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 0.0% of T2 Biosystems shares are owned by company insiders. Comparatively, 7.9% of Sonendo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, TTOO or SONX? T2 Biosystems has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Comparatively, Sonendo has a beta of 1.4, meaning that its share price is 40% more volatile than the S&P 500. Which has preferable earnings & valuation, TTOO or SONX? T2 Biosystems has higher earnings, but lower revenue than Sonendo. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioT2 Biosystems$7.68M0.03-$50.08MN/AN/ASonendo$44.40M0.00-$60.92M-$59.12-0.01 SummarySonendo beats T2 Biosystems on 6 of the 10 factors compared between the two stocks. Get Sonendo News Delivered to You Automatically Sign up to receive the latest news and ratings for SONX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SONX vs. The Competition Export to ExcelMetricSonendoDental equipment & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$129K$84.50K$6.10B$21.94BDividend YieldN/AN/A5.51%3.56%P/E Ratio0.00N/A85.6829.65Price / Sales0.000.00585.0197.81Price / CashN/AN/A26.3018.33Price / Book0.000.0013.254.61Net Income-$60.92M-$73.66M$3.30B$1.01B7 Day PerformanceN/AN/A4.70%0.14%1 Month PerformanceN/AN/A8.43%2.33%1 Year PerformanceN/AN/A88.01%13.85% Sonendo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SONXSonendoN/A$0.30flatN/A+500.0%$129K$44.40M0.00250Gap DownTTOOT2 BiosystemsN/A$0.01+0.8%N/A-99.4%$259K$7.68M0.00180IONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130SDCCQSmileDirectClubN/A$0.00flatN/A-91.7%$40K$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/A$0.00flatN/AN/A$26K$4.42M0.0072VRAYQViewRayN/AN/AN/AN/A$18K$102.21M0.00300AFIBAcutus MedicalN/A$0.00-44.4%N/A-99.6%$15K$7.16M0.00340NMRDNemaura Medical0.7451 of 5 starsN/AN/AN/A$4K$3.02K0.0040VIVEViveve MedicalN/A$0.00flatN/A-75.0%$2K$6.83M0.0070UTRSMinerva SurgicalN/A$0.00flatN/AN/A$1K$51.69M0.00160High Trading VolumeMOTSMotus GI0.0642 of 5 starsN/AN/A-99.7%$1K$319K0.0030 Related Companies and Tools Related Companies TTOO Alternatives IONM Alternatives SDCCQ Alternatives GMVDF Alternatives VRAYQ Alternatives AFIB Alternatives NMRD Alternatives VIVE Alternatives UTRS Alternatives MOTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SONX) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonendo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonendo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
